Literature DB >> 4052330

Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties.

M Magnani, V Stocchi, F Canestrari, M Dachà, P Balestri, M A Farnetani, D Giorgi, A Fois, G Fornaini.   

Abstract

A 14-month-old child who had a haemolytic episode when he was 5 years old, and with psychomotor retardation, was found to have decreased red cell hexokinase activity. The mutant enzyme was characterized by an increased affinity for glucose associated with an increased inhibition constant for glucose-1,6-diphosphate. Affinity for Mg ATP2-, heat stability and pH-optimum were normal. The isozymic pattern of the red cell enzyme was normal but all the molecular forms were present in reduced amounts. The kinetics of decay of hexokinase during cell ageing was also normal. Glucose consumption of the hexokinase deficient cells was 60-65% of the controls while the amount metabolized through the hexose monophosphate shunt was unchanged. Red cell 2,3-diphosphoglycerate and glucose-6-phosphate levels were normal in the proband but reduced in the erythrocytes of his parents, who were heterozygous for the defect but had normal haematological data. Comparison with the 13 previously reported cases of hexokinase deficiency confirms the broad phenotypic variability that characterizes this disorder.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052330     DOI: 10.1111/j.1365-2141.1985.tb04058.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency.

Authors:  M Magnani; L Chiarantini; V Stocchi; M Dachà; G Fornaini
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  A new metabolic muscle disease due to abnormal hexokinase activity.

Authors:  K R Poulton; S Nightingale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

3.  De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment.

Authors:  Volkan Okur; Megan T Cho; Richard van Wijk; Brigitte van Oirschot; Jonathan Picker; Stephanie A Coury; Dorothy Grange; Linda Manwaring; Ian Krantz; Colleen Clark Muraresku; Peter J Hulick; Holley May; Eric Pierce; Emily Place; Kinga Bujakowska; Aida Telegrafi; Ganka Douglas; Kristin G Monaghan; Amber Begtrup; Ashley Wilson; Kyle Retterer; Kwame Anyane-Yeboa; Wendy K Chung
Journal:  Eur J Hum Genet       Date:  2019-02-18       Impact factor: 4.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.